Hepatitis News : Baby Boomers With Hepatitis C Drive Demand for Liver Transplants
A Smart + Strong Site
Subscribe to:
Hep Magazine In Bulk
Hep Newsletter
Join Us:

Back to home » Hepatitis News » December 2012


December 10, 2012

Baby Boomers With Hepatitis C Drive Demand for Liver Transplants

Aging baby boomers make up the greatest demand for hepatitis C–related liver transplantations in the United States, according to research published in the December issue of Liver Transplantation and presented at the annual meeting of the American Academy for the Study of Liver Diseases (AASLD). The study found that the increased demand for liver transplants is driven by Americans born between 1941 and 1960, but it speculated that the demand might taper in the future as the population continues to age and is no longer healthy enough for transplants.

Researchers analyzed data on adults registered with the Organ Procurement and Transplantation Network (OPTN) between 1995 and 2010. They found 126,862 new candidates for a first liver transplant, 41 percent of whom had hepatitis C virus (HCV). The highest concentration of hep C among these candidates, divided by birth year in descending order of prevalence, was among those born between 1951 and 1955, 1956 and 1960, 1946 and 1950, and 1941 and 1945, respectively. These groups made up 81 percent of the new liver transplant applicants with hep C.

Between 2000 and 2010, those HCV-infected Americans born between 1941 and 1960 who also have hepatocellular carcinoma (HCC), the most common form of liver cancer, experienced a four-fold increase in liver transplant applications.

To read the news release via the AlphaGalileo Foundation, click here.

To read the study abstract, click here.

Search: HCV, hepatitis C, hep C, baby boomers, liver transplantation, Academy for the Study of Liver Diseases, AASLD, Organ Procurement and Transplantation Network, OPTN, hepatoceullar carcinoma, HCC, liver cancer.

Scroll down to comment on this story. Click here to visit the Hep Forums and ask questions about this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The Hep team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Quick Links
Current Issue
Hep TV
Services Directory
Conference News
Top Stories
Treatment News
Hep Exclusives
All About Hepatitis
• Hepatitis A
• Hepatitis B
• Hepatitis C
HCV/HIV Coinfection
Help Paying For Meds
Clinical Trials
Tell us what you think
Are you a regular coffee drinker?

Hepatitis C Reader Survey
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.